Search

everythinglearnresearchcommunity

for

Search:↓

Ritlecitinib significantly improves scalp hair regrowth in alopecia areata patients over time.

A PTH-based treatment improved hair regrowth better than ruxolitinib in a mouse model of hair loss.

Baricitinib is effective in promoting hair growth in severe alopecia areata.

Certain leukemia drugs can cause severe skin reactions that may require stopping treatment.

Eculizumab helps reduce blood transfusions and stabilize hemoglobin but increases infection risk and is expensive.

Baricitinib for severe alopecia areata is generally safe, with common side effects like infections and acne, and low rates of serious complications.

Ritlecitinib is effective and safe for treating alopecia areata, promoting significant hair regrowth.

Methotrexate is effective for rheumatoid arthritis but can cause side effects.

The cancer drugs bortezomib and lenalidomide cause skin side effects in many patients.

Ritlecitinib and baricitinib are effective for alopecia areata, but more research is needed to determine which is better.

Tofacitinib helps improve skin conditions in people with Down syndrome, especially alopecia areata.

Ritlecitinib is an effective new treatment for Alopecia Areata.

Leflunomide and anthralin may effectively treat severe alopecia areata.

Pegylated liposomal doxorubicin is as effective as conventional doxorubicin but causes fewer heart problems and side effects.

Baricitinib successfully treated severe hair loss.

Baricitinib may effectively treat nail changes in alopecia areata.

Baricitinib helps regrow hair in severe alopecia areata and is safe, but more research is needed.

A man with vitiligo and alopecia saw quick skin and hair improvement with ruxolitinib, but skin color gains were lost after stopping treatment.

Ritlecitinib effectively treats severe Alopecia Areata by reducing harmful immune activity in the skin.

CTP-543 effectively promotes hair regrowth in adults with moderate to severe alopecia areata.

Adjusting the medication tacrolimus resolved a boy's red nail beds after a stem cell transplant.

Anti-CD19 therapy may help treat SLE and NMOSD.

Thalidomide improved lupus symptoms but caused nerve damage in some patients.

A patient's grey hair regained color during treatment with adalimumab.

Baricitinib and ritlecitinib are recommended for severe alopecia areata, with other treatments available off-label.

Blocking certain pathways with kinase inhibitors may help treat cutaneous lupus erythematosus.

Ritlecitinib effectively regrows scalp, eyebrow, and eyelash hair in Asians with alopecia areata and is safe.

A patient with a new PLEC gene mutation showed symptoms of both muscular dystrophy and myasthenia gravis, which improved with steroid treatment.